What MCPairs Does
Get The Best Ideas for Your Projects
MCPairs© identifies matched molecular pairs and tracks how these changes affect key properties, turning complex SAR data into actionable insights.
Powered by the proprietary MedChemica MMPA database—the largest documented collection of medicinal chemistry ADMET knowledge, built from patents, public sources like ChEMBL, and consortium data—MCPairs© gives scientists the confidence to make evidence-based compound optimisation decisions.
Waring et al., Med. Chem. Commun., (2011), 2, 775
Why MCPairs
Key Benefits
Powered by the world’s largest matched molecular pair database, MCPairs gives you good ideas leading to fewer cycles of DMTA.
Save time and money
MCPairs enables faster optimisation by both reducing the number of compounds made and tested, and the number of cycles.
Explainable AI
Robust data analysis with a high success rate in problem solving. Allows for internal and external presentations that look professional with easy to present the data.
Data-backed design decisions
MCPairs uses context-dependent MMPA. By finding matched pairs our tools help chemists gain maximum insight into designing better compounds.
Web-based access
Accessed through modern web-browsers to MedChemica’s secure cloud servers, tools are built for speed and global access.
API integration
MCPairs automatically updates from internal databases to keep knowledge current, letting users instantly look up matched pairs and perform SAR analysis.
Supports proprietary and public data
For organisations with compounds and measurements, a secure MCPairs server will extract knowledge and build a unique database of corporate knowledge private to you.
A Suite of Secure Compound Design Tools
Matched Molecular Pair Analysis Tools
Specialised modules for discovering and analysing matched molecular pairs.
Explore Your Data
Unlock insights from your data quickly and efficiently.
Predict Outcomes Faster
Make confident predictions that are fully explainable.
Your Chemistry Toolbox
